S. Bansilal

S. Pocock, T. Henry, G. Dangas, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

The SI! Program for Cardiovascular Health Promotion in Early Childhood: A Cluster-Randomized Trial.

V. Fuster, R. Vedanthan, J. Fernández-Alvira, 2015, Journal of the American College of Cardiology.

iabetic Cardiomyopathy : Insights into Pathogenesis , iagnostic Challenges , and Therapeutic Options

Mario J. Garcia, S. Bansilal, W. Tang, 2022 .

Role of Multivessel Intervention in Diabetes Mellitus Advances in interventional procedures and medical therapy offer promising treatment options for the diabetic patient population.

Samin K. Sharma, M. Farkouh, S. Bansilal, 2008 .

Different Lifestyle Interventions in Adults from Underserved Communities: The FAMILIA Trial.

A. Kasarskis, V. Fuster, Z. Fayad, 2019, Journal of the American College of Cardiology.

Safety and efficacy of bivalirudin monotherapy in patients with non-ST-segment elevation acute coronary syndromes with positive biomarkers undergoing percutaneous coronary intervention: a report from the Acute Catheterization and Urgent Intervention Triage Strategy trial.

G. Stone, A. Kirtane, G. Dangas, 2020, Coronary artery disease.

Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials

G. Stone, A. Kirtane, G. Dangas, 2015, Circulation. Cardiovascular interventions.

31. Bleeding Definitions

R. Mehran, S. Bansilal, D. Aronson, 2014 .

CRP has little incremental value over traditional cardiovascular risk factors in risk stratification

M. Farkouh, S. Bansilal, V. Mathew, 2007, Nature Clinical Practice Cardiovascular Medicine.

A Comprehensive Lifestyle PeerGroup-Based Intervention onCardiovascular Risk Factors

R. Vedanthan, J. Fernández-Alvira, S. Bansilal, 2022 .

Long-term cardiovascular outcomes in patients with angina pectoris presenting with bundle branch block.

H. Wiste, M. Farkouh, G. Reeder, 2011, The American journal of cardiology.

A polypill strategy to improve adherence: results from the FOCUS project.

V. Fuster, S. Pocock, Sidney C. Smith, 2014, Journal of the American College of Cardiology.

Clinical Risk Stratification in the Emergency Department Predicts Long-Term Cardiovascular Outcomes in a Population-Based Cohort Presenting With Acute Chest Pain: Primary Results of the Olmsted County Chest Pain Study

H. Wiste, M. Farkouh, D. Holmes, 2009, Medicine.

Little Beacons of Change: Targeting Preschool Children to Drive a Culture of Health.

V. Fuster, R. Vedanthan, S. Bansilal, 2016, Global heart.

gSCIENCE ORIGINAL R ESEARCH Cardiovascular Risk Surveillance to Develop a Nationwide Health Promotion Strategy

M. Woodward, M. Farkouh, A. Charney, 2012 .

to improve adherence : results from FOCUS ( Fixed-dose Combination Drug for Secondary Cardiovascular Prevention ) Project

S. Pocock, M. Farkouh, M. Roncaglioni, 2014 .

JUPITER strikes earth

V. Fuster, S. Bansilal, 2009, Nature Clinical Practice Cardiovascular Medicine.

Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial.

C. Cannon, L. Wallentin, R. Becker, 2016, American heart journal.

Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease.

Deepak L. Bhatt, A. Parkhomenko, M. Sabatine, 2018, Journal of the American College of Cardiology.

Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis

C. Held, P. Armstrong, C. Cannon, 2018, American heart journal.

Use of prasugrel and clinical outcomes in African‐American patients treated with percutaneous coronary intervention for acute coronary syndromes

Sunil V. Rao, S. Pocock, T. Henry, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Looking beyond haemodynamics in chronic heart failure.

S. Bansilal, R. Desai, 2004, Postgraduate medical journal.

Is the Best Disease-Guided

S. Bansilal, V. Fuster, 2022 .

Risk profiling patients for selective use of drug-eluting stents is warranted

V. Fuster, M. Farkouh, S. Bansilal, 2007, Nature Clinical Practice Cardiovascular Medicine.

Dietary sodium intake among US adults with hypertension, 1999–2012

S. Bansilal, K. Moazzami, E. Dolmatova, 2018, Journal of hypertension.

Declining Coronary Artery Bypass‐Related Mortality: More Than Meets the Eye?

Deepak L. Bhatt, S. Bansilal, 2012, Clinical cardiology.

(18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.

V. Fuster, J. Machac, Z. Fayad, 2007, Journal of the American College of Cardiology.

Long-term use of ticagrelor in patients with prior myocardial infarction.

Marc P. Bonaca, Deepak L. Bhatt, M. Sabatine, 2015, The New England journal of medicine.

Family-Based Approaches to Cardiovascular Health Promotion.

A. Kasarskis, V. Fuster, E. Schadt, 2016, Journal of the American College of Cardiology.

Global burden of CVD: focus on secondary prevention of cardiovascular disease.

V. Fuster, S. Bansilal, José M. Castellano, 2015, International journal of cardiology.

The Nonvitamin K Antagonist Oral Anticoagulants and Atrial Fibrillation: Challenges and Considerations.

S. Bansilal, Anna Plitt, 2017, Journal of atrial fibrillation.

A Diabetes-Atrial Fibrillation Conundrum: Does Duration Trump Glycemia?

Z. Bloomgarden, S. Bansilal, 2016, Journal of the American College of Cardiology.

Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry).

Samin K. Sharma, J. Halperin, G. Dangas, 2015, The American journal of cardiology.

Pathophysiology of coronary thrombosis

V. Fuster, S. Bansilal, 2011 .

Stress testing and troponin in unstable coronary syndromes: the status trial-clinical outcomes and resource use.

M. Farkouh, S. Bansilal, J. Chesebro, 2006, The American heart hospital journal.

Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study

S. Pocock, T. Henry, S. Kapadia, 2017, American heart journal.

Ticagrelor for acute coronary syndromes

Marc P. Bonaca, M. Sabatine, S. Bansilal, 2013, Expert review of cardiovascular therapy.

Focus on : Promotion of Cardiovascular Health ( II ) Promotion of Cardiovascular Health at Three Stages of Life : Never Too Soon , Never Too Late

J. Castellano, S. Bansilal, J. Peñalvo, 2019 .

Promotion of cardiovascular health at three stages of life: never too soon, never too late.

V. Fuster, J. Castellano, S. Bansilal, 2014, Revista espanola de cardiologia.

Strategies for multivessel revascularization in patients with diabetes.

Akshay S. Desai, Sameer Bansilal, George Dangas, 2012, The New England journal of medicine.

Cardiovascular risk surveillance to develop a nationwide health promotion strategy: the grenada heart project.

V. Fuster, M. Woodward, M. Farkouh, 2012, Global heart.

Safety and Efficacy of Bivalirudin in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: From the REPLACE-2, ACUITY and HORIZONS-AMI Trials.

G. Stone, A. Kirtane, G. Dangas, 2016, The American journal of cardiology.

Optimal treatment of the diabetic patient with multivessel disease

V. Fuster, M. Farkouh, S. Bansilal, 2008, Current cardiology reports.

Resistant in‐stent restenosis in the drug eluting stent era

Samin K. Sharma, G. Dangas, R. Mehran, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Antithrombotic strategy variability in ATrial fibrillation and obstructive coronary disease revascularized with PCI-rationale and study design of the prospective observational multicenter AVIATOR 2 registry.

G. Dangas, R. Mehran, U. Baber, 2015, American heart journal.

Effect of Intensive Versus Standard Blood Glucose Control in Patients With Type 2 Diabetes Mellitus in Different Regions of the World: Systematic Review and Meta-analysis of Randomized Controlled Trials

M. Farkouh, S. Bansilal, J. Udell, 2015, Journal of the American Heart Association.

C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention.

Samin K. Sharma, M. Farkouh, A. Kini, 2009, American heart journal.

Grenada Heart Project-Community Health ActioN to EncouraGe healthy BEhaviors (GHP-CHANGE): A randomized control peer group-based lifestyle intervention.

V. Fuster, M. Farkouh, R. Vedanthan, 2019, American heart journal.

Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes.

V. Fuster, C. Spettell, J. Castellano, 2016, Journal of the American College of Cardiology.

Polypill: Can its Potential Enhancement of Efficacy Trigger New Interest?

S. Bansilal, J. Chao, 2016, Global heart.

A Comprehensive Lifestyle Peer Group-Based Intervention on Cardiovascular Risk Factors: The Randomized Controlled Fifty-Fifty Program.

V. Fuster, R. Vedanthan, J. Fernández-Alvira, 2016, Journal of the American College of Cardiology.

A polypill strategy to improve global secondary cardiovascular prevention: from concept to reality.

V. Fuster, G. Sanz, S. Bansilal, 2014, Journal of the American College of Cardiology.

The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 Trial

Marc P. Bonaca, Deepak L. Bhatt, Lawrence A Leiter, 2018, American heart journal.

The role of reduced heart rate volatility in predicting disposition from the emergency department

L. Richardson, S. Bansilal, G. Loo, 2016, Emergency Medicine Journal.

Low intraoperative heart rate volatility is associated with early postoperative mortality in general surgical patients: a retrospective case–control study

Gregory W. Fischer, Sameer Bansilal, Matthew A. Levin, 2016, Journal of Clinical Monitoring and Computing.

Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study.

H. Ghofrani, R. Benza, A. Frost, 2021, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54.

Marc P. Bonaca, Deepak L. Bhatt, M. Sabatine, 2022, European heart journal.

Promoting Cardiovascular and Cerebrovascular Health

V. Fuster, S. Bansilal, 2010, Stroke.

Association Between a Social-Business Eating Pattern and Early Asymptomatic Atherosclerosis.

V. Fuster, S. Pocock, E. Guallar, 2016, Journal of the American College of Cardiology.

Role of insulin resistance and hyperglycemia in the development of atherosclerosis.

V. Fuster, M. Farkouh, S. Bansilal, 2007, The American journal of cardiology.

New insights into the link between cardiovascular disease and depression

Philip D. Harvey, M. Farkouh, A. Reichenberg, 2007, International journal of clinical practice.

Assessment for residual disease after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension

S. Bansilal, G. Heresi, S. Hoernig, 2022, ERJ Open Research.

Child Health Promotion in Underserved Communities: The FAMILIA Trial.

A. Kasarskis, V. Fuster, Z. Fayad, 2019, Journal of the American College of Cardiology.

Child Health Promotion in UnderservedCommunities

A. Kasarskis, V. Fuster, Z. Fayad, 2019 .

Serum cystatin C and increased coronary heart disease prevalence in US adults without chronic kidney disease.

M. Farkouh, P. Muntner, S. Bansilal, 2008, The American journal of cardiology.

The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry.

Sameer Bansilal, George Dangas, Krishnan Ramanathan, 2012, American heart journal.

Long-term outcomes in non-diabetic patients with metabolic syndrome undergoing revascularization for multi-vessel coronary artery disease.

D. Faxon, M. Farkouh, E. Fisher, 2008, Atherosclerosis.

WITHDRAWN: Global burden of CVD: Focus on secondary prevention of cardiovascular disease

V. Fuster, J. Castellano, S. Bansilal, 2016 .

Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography.

V. Fuster, M. Woodward, Z. Fayad, 2011, American heart journal.

Coronary artery disease: Appropriate testing for stable ischaemic heart disease

Z. Fayad, S. Bansilal, 2014, Nature Reviews Cardiology.

C. Cannon, L. Wallentin, R. Becker, 2016, American Heart Journal.

Conscious Sedation Versus General Anesthesia During Endovascular Therapy for Acute Anterior Circulation Stroke: Preliminary Results From a Retrospective, Multicenter Study

K. Furie, G. Hankey, R. Sacco, 2011 .

Rationale and Design of Family‐Based Approach in a Minority Community Integrating Systems–Biology for Promotion of Health (FAMILIA)

A. Kasarskis, V. Fuster, E. Schadt, 2017, American heart journal.

Long-term use of ticagrelor in patients with prior myocardial infarction.

Marc P. Bonaca, Deepak L. Bhatt, M. Sabatine, 2015, The New England journal of medicine.

A Comprehensive Lifestyle Peer Group-Based Intervention on Cardiovascular Risk Factors: The Randomized Controlled Fifty-Fifty Program.

V. Fuster, R. Vedanthan, J. Fernández-Alvira, 2016, Journal of the American College of Cardiology.

Family-Based Approaches to Cardiovascular Health Promotion.

A. Kasarskis, V. Fuster, E. Schadt, 2016, Journal of the American College of Cardiology.

Strategies for multivessel revascularization in patients with diabetes.

G. Dangas, M. Farkouh, K. Ramanathan, 2012, The New England journal of medicine.

Edinburgh Research Explorer Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation

G. Breithardt, D. Singer, G. Hankey, 2017 .

EFFICACY AND SAFETY OF TICAGRELOR FOR LONG-TERM SECONDARY PREVENTION OF ATHEROTHROMBOTIC EVENTS IN PATIENTS WITH PRIOR MI AND MULTIVESSEL CORONARY DISEASE: INSIGHTS FROM THE PEGASUS-TIMI 54 TRIAL

Marc P. Bonaca, Deepak L. Bhatt, M. Sabatine, 2016 .

The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry.

V. Fuster, M. Domanski, G. Dangas, 2012, American heart journal.

Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options.

S. Bansilal, Chintan N. Mehta, Michael E. Farkouh, 2008, The American journal of medicine.